Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$993,223
+$136,965 QoQ
Shares Held
3,947
+0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#2,547
of 4,153 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Granite Group Advisors, LLC holds $5,168,137 across 5 Drug Manufacturers - General names. ABBV ranks #2 (19.2% of the industry book) .
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $993,223 | 3,947 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $856,258 | 3,937 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $862,778 | 3,776 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $905,784 | 3,912 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $724,660 | 3,904 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $817,966 | 3,904 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,440,613 | 8,107 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $1,594,256 | 8,073 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $2,065,100 | 12,040 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $2,148,051 | 11,796 | Shares | Sole | 2024-05-31 | |
| 2023-12-31 | $1,840,268 | 11,875 | Shares | Sole | 2024-04-03 | |
| No filing history on record for this holder in this stock. | ||||||